NEW YORK, Oct 22 (Reuters) - Citigroup ( C/PN ) has

promoted three senior healthcare investment bankers - Sumit

Khedekar, Nishant Jadav and Michael Guarino - in the bank's push

to win more deals in the industry, an internal memo seen by

Reuters on Tuesday showed.

Sumit Khedekar, who had led the Wall Street bank's biopharma

unit and healthcare investment banking in the Americas, has been

named head of healthcare globally, said Chuck Adams, global head

of the healthcare, consumer and retail investment-banking groups

at Citi, in the memo.

The appointments reflect the accomplishments of the

three bankers in the biopharma and healthcare services sectors,

said Adams in the memo, noting also that healthcare was a key

part of Citi's strategy to grow its investment banking

franchise.

A Citi spokesperson confirmed the contents of the memo.

Khedekar joined Citi in 2022 after working at Credit Suisse

and Bank of America, according to his LinkedIn profile.

Nishant Jadav was named global head of healthcare services.

Michael Guarino will assume Jadav's role as head of healthcare

services in North America, according to the memo.

Jadav joined Citi in 2022 after serving about 17 years at

Bank of America, his LinkedIn profile showed.

Guarino, a former Goldman Sachs investment banker, has

headed healthcare technology investment banking in North America

since joining Citi in 2022.

Citi has recently advised on some notable healthcare deals,

including Catalent's ( CTLT ) $16.5 billion sale to the parent

company of Novo Nordisk.